13-cis Retinoic Acid (Isotretinoin) and Sperm Production

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This study aims to evaluate the effectiveness of weekly administration of isotretinoin (40 mg) in increasing sperm production in men with oligozoospermia, a condition characterized by a low sperm count. Participants will be randomized into two groups: one receiving isotretinoin and the other a placebo. The primary outcome will be the change in sperm production over 20 weeks of treatment.
Epistemonikos ID: 765106887ba8733230fb0e081c80ec761c32d98c
First added on: Dec 01, 2024